[Hidradenitis suppurativa treated with infliximab]

Hidradenitis suppurativa Research

Author(s): Obadia DL, Daxbacher EL, Jeunon T, Gripp AC

Hidradenitis suppurativa is an inflammatory disease with difficult treatment. Currently, the anti-TNF alfa therapy, with monoclonal antibodies (‘biological therapy’), has been shown as a new alternative. However, clinical trials assessing the efficacy of these drugs to treat hidradenitis suppurativa have not yet been published. A case in which the use of infliximab did not result in significant clinical improvement is described.

Dermatology Journal and/or Publisher

Journal Name: Anais brasileiros de dermatologia
Journal Abbreviation: An Bras Dermatol
Journal Date Published: 2010-03-01

National Center for Biotechnology Information

PMID: 20191188
Article Source: http://www.ncbi.nlm.nih.gov/pubmed/20191188
Lasted Revision: 2015-11-19

Abstract Source: National Center for Biotechnology Information, U.S. National Library of Medicine Abstract Query for Hidradenitis suppurativa (HS).


Leave a reply

HSAWARENESS.ORG | Fighting for Hidradenitis suppurativa (HS), a.k.a Acne Inversa Patient and Doctor Awareness ©2019 hidradenitissuppurativaawareness.org  All Rights Reserved. Your use of this website constitutes explicit agreement to our Terms of Use and Privacy Policies. This website does not provide medical advice, diagnosis or treatment.

Log in with your credentials

Forgot your details?